Clinical trials
Prognosis clinical trials
Below are recruiting prognosis clinical trials, each written for real people, not researchers. We’re tracking 219 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06015802Recruiting
Predicting pituitary tumor behavior with markers and scans
This study looks at whether blood and tissue markers, along with imaging features, can predict how aggressive a pituitary neuroendocrine tumor is and how it may affect long-term health. It aims to improve treatment decisions by better understanding these tumors.
Guangzhou, GuangdongAges 18–70 - NCT06076226Recruiting
Donor telomere length and leukemia transplant outcomes
This trial looks at whether the length of telomeres (the protective caps at the ends of chromosomes) in donor blood cells affects recovery for people with acute leukemia who receive a stem cell transplant. It aims to see if a simple donor blood test can predict how well the transplant works.
Hangzhou, ZhejiangAges 5–90 - NCT06069232Recruiting
Aortic valve disease risk and prognosis study
This study is looking at people with aortic valve disease to understand what factors affect their risk and to build a model that predicts how the disease will progress. Researchers hope this will help doctors better care for patients in the future.
Guangzhou, GuangdongAges 18–100 - NCT04785976Recruiting
Study of long-term outcomes after a ruptured brain aneurysm bleed
This trial is a long-term follow-up study of people who come to the emergency room with a ruptured brain aneurysm (bleeding in the space around the brain). It helps doctors understand what outcomes are most common and what may affect recovery over time.
Beijing, Beijing MunicipalityAges Any age - NCT06160596Recruiting
Understanding long-term cancer survival in hard-to-treat tumors
This study looks at why some people with hard-to-treat cancers live much longer than expected. It collects tumor samples to search for clues that might help future patients.
VillejuifAges 18 years+ - NCT04916197RecruitingPhase 4
Dexmedetomidine sedation after stroke clot removal
This Phase 4 study tests whether using a specific calming medicine (dexmedetomidine) for a longer period after a successful clot-removal procedure helps people do better in the long term. It may help improve outcomes after ischemic stroke where the clot is successfully treated.
Beijing, Beijing MunicipalityAges 18–80 - NCT06204406Recruiting
Kidney-sparing treatment for upper tract urothelial cancer
This study looks at how well patients do when they have kidney-sparing treatment (instead of complete kidney removal) for upper tract urothelial carcinoma. It helps doctors understand which patients can safely avoid losing their kidney.
Shanghai, Shanghai MunicipalityAges 18–90 - NCT06198868Recruiting
MRD blood test to guide treatment in lung cancer
This trial uses a blood test (ctDNA and CTC) to check for minimal residual disease (MRD) after treatment for stage IIA-IIIC non-small cell lung cancer. The goal is to see if MRD can help predict whether the cancer will come back and guide decisions on extra treatment to prevent recurrence.
Nanjing, JiangsuAges 18 years+ - NCT07870148Recruiting
Breast cancer and thyroid antibodies study
This study looks at whether the body's immune response to the thyroid is linked to breast cancer. It may help doctors understand how breast cancer behaves and how to treat it better.
MilanAges 18–80 - NCT06206083Recruiting
Studying endometrial cancer types to predict outcomes
This study looks at the specific type of endometrial cancer (endometrioid) in Mexican patients to understand how different molecular features affect prognosis. It may help doctors better tailor treatment to the individual.
Mexico City, Mexico CityAges 18 years+ - NCT06286267Recruiting
AI tool for diagnosing breast phyllodes tumors
This trial uses an artificial intelligence system to help doctors more accurately diagnose and predict the outcome of breast phyllodes tumors, which are rare breast growths. It aims to improve how these tumors are identified and managed.
Guangzhou, GuangdongAges Any age - NCT06379386Recruiting
Long-term results of TAVR for severe aortic valve regurgitation
This trial follows people who have severe aortic valve regurgitation and get a TAVR. It looks at how well the valve works over time and how patients do in the long run.
Xi'an, ShannxiAges 18 years+ - NCT06383208Recruiting
Heart and kidney risk study for people with both diseases
This study looks at how well we can predict heart and kidney problems in people who have both coronary heart disease and chronic kidney disease. By analyzing certain markers, researchers hope to create a better risk assessment tool.
Beijing, Beijing MunicipalityAges 18–80 - NCT07847164Recruiting
Hip fracture recovery study in older adults
This study follows older adults in China who have had a hip fracture to understand their recovery and what factors affect it. It aims to improve care and outcomes for people with hip fractures.
Beijing, Beijing MunicipalityAges 60 years+ - NCT07847190RecruitingPhase 2
Adding paclitaxel to standard chemotherapy for tough testicular cancer
This trial tests if adding a drug called paclitaxel to the standard chemotherapy combination (BEP) can improve outcomes for people with aggressive testicular cancer. It is for those whose tumor markers did not drop as fast as expected after the first round of chemo.
MoscowAges 16 years+ - NCT07838207Recruiting
Molecular markers and outcomes in early-stage endometrial cancer
This study looks at women with certain high-risk types of endometrial cancer that have not spread into the muscle wall of the uterus. It aims to understand how these cancers behave and whether lymph node testing is needed, which could help guide treatment decisions.
Barcelona, BarcelonaAges 18 years+ - NCT04847752Recruiting
Predicting outcomes after stroke from artery plaque
This study looks at factors that can help predict recovery and risk after an ischemic stroke caused by plaque buildup in a major artery. It may help doctors better forecast prognosis and tailor follow-up care for people like you.
WuhanAges Up to 80 years - NCT03233087Recruiting
Study to predict outcomes in aortic dissection
This study collects medical information and blood-test timing data to learn how to diagnose aortic dissection sooner and predict outcomes. It may help doctors better plan care for people with suspected or confirmed aortic dissection.
Beijing, Beijing MunicipalityAges 18–80 - NCT07813377Recruiting
Blood clotting test to predict outcomes after brain tumor surgery
This study looks at a special blood test (called thromboelastography) that checks how well your blood clots. The goal is to see if this test can predict how the surgery goes and whether you might get a blood clot after surgery. If you join, the test will be done before and after your brain surgery, and you will be monitored for any blood clot complications.
BarcelonaAges 18 years+ - NCT06001073Recruiting
Heart and brain disease health prediction study
This study uses advanced health data to predict how heart and brain conditions may progress. It aims to help doctors provide better care for people with these diseases.
Xi'an, ShaanxiAges 3–80 - NCT05965362Recruiting
Study biomarkers to predict outcomes in heart infection
This study looks at blood and other lab test results (“biomarkers”) to better predict what may happen to people with infective endocarditis, a serious infection of the heart lining or heart valves. Your information may help doctors estimate risk and choose care more safely and effectively.
Xi'an, ShaanxiAges 18 years+ - NCT05775432Recruiting
Study outcomes for people receiving heart transplants
This study follows people with severe (end-stage) heart failure who are evaluated for and receive a heart transplant. It helps doctors understand what outcomes to expect after transplant, which can guide future care.
Xi'an, ShaanxiAges 3–80 - NCT05999188Recruiting
Aortic dissection study in China
This study looks at the features and outcomes of aortic dissection in Chinese patients. It aims to better understand the condition and improve care.
Xi'an, ShaanxiAges 18–80 - NCT03116490Recruiting
Compares anesthesia types for recovery after hip fracture surgery
This study looks at whether using regional anesthesia or general anesthesia affects outcomes after hip fracture surgery in older adults. It may help doctors choose the safest anesthesia option for recovery and prognosis.
Wenzhou, ZhejiangAges 60 years+
Hear when a new Prognosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for prognosis?
- Yes. Clin2 currently lists 219 recruiting prognosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a prognosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a prognosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.